1-aminoproline: constituent of linatine; thought to be responsible for in vivo toxicity of linseed meal for turkey poults; RN given refers to(D)-isomer; pyridoxine antag [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 273022 |
| CHEBI ID | 188977 |
| SCHEMBL ID | 199062 |
| MeSH ID | M0059065 |
| Synonym |
|---|
| 1-aminoproline |
| 15265-22-2 |
| nsc-117847 |
| nsc117847 |
| FT-0662030 |
| 1-aminopyrrolidine-2-carboxylic acid |
| d-1-amino-2-pyrrolidinecarboxylic acid |
| CHEBI:188977 |
| AKOS006223022 |
| SCHEMBL199062 |
| 1-aminoproline # |
| n-aminoproline |
| OUCUOMVLTQBZCY-UHFFFAOYSA-N |
| (2s,4s)-aminoproline |
| mfcd18071472 |
| SY343120 |
| amino-l-proline |
| Class | Description |
|---|---|
| proline derivative | An amino acid derivative resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of proline by a heteroatom. The definition normally excludes peptides containing proline residues. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||